Downregulation of VRK1 Inhibits Progression of Lung Squamous Cell Carcinoma through DNA Damage

Figure 4

(a-b) CCK8 assay of cell activity in shVRK1-transfected, shNC-transfected, and control groups of NCI-H520 and SK-MES-1 cells; (c–d) flow cytometry assay of cell cycle in shVRK1-transfected, shNC-transfected, and control groups of NCI-H520 and SK-MES-1 cells and (e–f) their quantitative plots.

(a)

(b)

(c)

(d)

(e)

(f)